1. Identifying urotropine derivatives as co-donors of formaldehyde and nitric oxide for improving antitumor therapy.
- Author
-
Zhang Y, Feng S, Meng X, Luo J, Xu Y, and Ning X
- Subjects
- Animals, Antineoplastic Agents chemical synthesis, Apoptosis drug effects, Cell Line, Tumor, Cell Proliferation drug effects, Dose-Response Relationship, Drug, Drug Carriers chemistry, Liposomes chemistry, Methenamine chemistry, Mice, Nitric Oxide Donors chemical synthesis, Nitrosamines chemical synthesis, Nitrosamines therapeutic use, Polyamines chemical synthesis, Antineoplastic Agents therapeutic use, Formaldehyde metabolism, Neoplasms drug therapy, Nitric Oxide metabolism, Nitric Oxide Donors therapeutic use, Polyamines therapeutic use
- Abstract
A pharmacophore integration strategy was utilized to develop the first co-donor of formaldehyde and nitric oxide (FANO), composed of urotropine derived nitramine/nitrosamine. FANO simultaneously generated formaldehyde and nitric oxide on-demand, resulting in synergistic anticancer effects. Importantly, liposomal formulation of FANO effectively inhibited tumor growth with minimal side-effects, providing a potent combined nitric oxide therapy for malignancy.
- Published
- 2021
- Full Text
- View/download PDF